SCHEMBL17596307

SCHEMBL17596307

CC1Cn2c(nnc2-c2ccc(F)c(F)c2)CN1C(=O)c1cccc(C(F)(F)F)c1Cl

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17596305 1.00 P2RX7 (0.82) P2RX7
SCHEMBL17595616 0.95 P2RX7 (0.82) P2RX7
SCHEMBL17595617 0.95 P2RX7 (0.82) P2RX7
SCHEMBL20099687 0.94 P2RX7 (0.81) P2RX7
SCHEMBL17595638 0.92 P2RX7 (0.81) P2RX7
SCHEMBL17595639 0.92 P2RX7 (0.81) P2RX7
SCHEMBL17595683 0.90 P2RX7 (0.84) P2RX7
SCHEMBL17595684 0.90 P2RX7 (0.84) P2RX7
SCHEMBL17596212 0.90 P2RX7 (1.00) P2RX7
SCHEMBL17596213 0.90 P2RX7 (1.00) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191488-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES Janssen Pharmaceutica, N.V. (BE) 2017-07-19 EP claimed
WO-2016039983-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2016-03-17 WO claimed
EP-3191488-B1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2019-08-14 EP disclosed
EP-3191488-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES Janssen Pharmaceutica, N.V. (BE) 2017-07-19 EP disclosed
WO-2016039983-A1 P2X7 MODULATING N-ACYL-TRIAZOLOPYRAZINES JANSSEN PHARMACEUTICA NV (BE) 2016-03-17 WO disclosed